Clinical trialNCT06928246RecruitingPhase 1Interventional

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

SponsorDaniel KaplanEnrollment8Atopic Dermatitis (AD)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to understand cellular and molecular interactions in the skin of participants with mild-to-moderate AD, and how botulinum toxin alters these interactions.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel Kaplan, MD, PhD
University of Pittsburgh
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Upmc Department of Dermatology
Pittsburgh, Pennsylvania, United States
Joe Tung, MD, MBA
Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Daniel H Kaplan, MD, PhDJoe K Tung, MD, MBA
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Onabotulinum Toxin Type A - Phase 1bOnabotulinum Toxin Type A - Phase 2

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jul 2025
Primary completion: 15 Dec 2026
Completion: 31 Jan 2027
Last update posted: 4 May 2026
Registered enrollment: 8
Registry id: NCT06928246

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.